« Back to Record
Citation APA

Arain, A., Verrando, R., Bruckers, L., Matheï, C., Buntinx, F., van Vlierberghe, H., Francque, S., Laleman, W., Moreno, C., Janssens, F., Nevens, F., Bourgeois, S., Robaeys, G., De Galocsy, C., Henrion, J., Deltenre, P., D'Heygere, F., George, C., Bastens, B., & Van Overbeke, L. (2016). Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs. Journal of medical virology, 88(1), 94-99. doi:10.1002/jmv.24308


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/226966

Arain, A., Verrando, R., Bruckers, L., Matheï, C., Buntinx, F., van Vlierberghe, H., Francque, S., Laleman, W., Moreno, C., Janssens, F., Nevens, F., Bourgeois, S., Robaeys, G., De Galocsy, C., Henrion, J., Deltenre, P., D'Heygere, F., George, C., Bastens, B., & Van Overbeke, L. (2016). Belgian experience with triple therapy with boceprevir and telaprevir in genotype 1 infected patients who inject drugs. Journal of medical virology, 88(1), 94-99. doi:10.1002/jmv.24308